Natural-killer-(NK)-cell activity and blood levels of interleukin 2 (IL-2), dehydroepiandrosterone (DHEA), DHEA sulphate (DHEA-S) and cortisol were measured in 17 patients with major depression and 10 control subjects. Depression severity was evaluated using the Zung Self-rating Depression Scale. NK-cell activity and IL-2 levels were measured using a chromium-51 release test and an enzyme-linked immunosorbent assay, respectively. Radioimmunoassays were used to measure serum cortisol, DHEA and DHEA-S. As would be expected, patients with major depression had a higher score on the Zung Self-rating Depression Scale than healthy controls. Compared with controls, NK-cell activity and levels of cortisol and DHEA were reduced in patients with major depression, whereas IL-2 levels were increased. No difference was observed in DHEA-S levels between patients and controls. A reduction in NK-cell activity and DHEA levels, and an increase in IL-2 levels appear to be associated with major depression. Whether these changes are the cause or the consequence of the depression remains to be determined.
JozukaH: Panic attacks and serum IgE levels in depressive states (in Japanese). Seishin-Igaku1988; 25: 87–91.
2.
JozukaH: T lymphocyte subsets in major depressions (in Japanese). Teishin-Igaku1988; 40: 477–482.
3.
JozukaH: T lymphocyte subsets in panic disorders (in Japanese). Seishin-Igaku1989; 31: 1336–1340.
4.
JozukaH: Immunological studies in anxiety and depressive states (in Japanese). Teishin-Igaku1990; 42: 599–605.
5.
JozukaH: Endogenous psychiatric disorders and immune responses (in Japanese). IMAGO (Seidosha, Tokyo)1993; 12: 122–131.
6.
MasekKPetrovickyPSevcikJZidekZFrankovaD: Past, present and future of psychoneuroimmunology. Toxicology2000; 142: 179–188.
7.
WebsterJITonelliLSternbergEM: Neuroendocrine regulation of immunity. Annu Rev Immunol2002; 20: 125–163.
8.
RaisonCLMillerAH: The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry2001; 6: 277–294.
9.
SluzewskaARybakowskiJBosmansESobieskaMBerghmansRMaesM: Indicators of immune activation in major depression. Psychiatry Res1996; 64: 161–167.
10.
SluzewskaA: Indicators of immune activation in depressed patients. Adv Exp Med Biol1999; 461: 59–73.
11.
IrwinM: Immune correlates of depression. Adv Exp Med Biol1999; 461: 1–24.
12.
MaesMBosmansESuyEVandervorstCDe JonckheereCRausJ: Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology1990–1991; 24: 115–120.
13.
MaesMBonaccorsoSMarinoVPuzellaAPasquiniMBiondiM: Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry2001; 6: 475–480.
14.
van WestDMaesM: Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuroendocrinol Lett1999; 20: 11–17.
15.
NishikazeO: Stress and adaptation in humans — aging, illness, psychosocial stress (in Japanese). Rinsho Byori1994; 42: 321–330.
16.
NishikazeOFuruyaE: Stress and anticortisols—17-ketosteroid sulfate conjugate as a biomarker in tissue repair and recovery (in Japanese). J UOEH1998; 20: 273–295.
GoodyerIMHerbertJAlthamPMPearsonJSecherSMShiersHM: Adrenal secretion during major depression in 8- to 16-year-olds. I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med1996; 26: 245–256.
OsumiK: Natural killer cell activity test (in Japanese). Rinsho Byori1981; 45 (Suppl): 299–309.
21.
BaulieuEE (ed): Neurosteroids.Totowa: Humana Press, 1990.
22.
ZungWWRichardsCBShortMJ: Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry1965; 13: 508–515.
23.
CaldwellCLIrwinMLohrJ: Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol Psychiatry1991; 30: 1131–1138.
24.
IrwinMLacherUCaldwellCL: Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med1992; 22: 1045–1050.
25.
MohlPCHuangLBowdenCFischbachMVogtsbergerKTalalN: Natural killer cell activity in major depression. Am J Psychiatry1987; 144: 1619.
26.
RookAHHooksJJQuinnanGVLaneHCManischewitzJFMacherAM: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol1985; 134: 1503–1507.
27.
WeizmanRLaorNPodliszewskiENottiIDjaldettiMBesslerH: Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry1994; 35: 42–47.
28.
CarsonWEYuHDierksheideJPfefferKBouchardPClarkR: A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol1999; 162: 4943–4951.
29.
MaesMCapuronLRavaudAGualdeNBosmansEEgyedB: Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology2001; 24: 130–140.
30.
KatholRG: Circannual rhythm and peak frequency of corticosteroid excretion: relationship to affective disorder. Psychiatr Med1985; 3: 53–63.
31.
HermanJPWatsonSJ: Stress regulation of mineralocorticoid receptor heteronuclear RNA in rat hippocampus. Brain Res1995; 677: 243–249.
LoriaRMPadgettDAHuynhPN: Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol1996; 150: S209–S220.
34.
FuruyaEMaezawaMNishikazeO: 17-KS sulfate as a biomarker in psychosocial stress (in Japanese). Rinsho Byori1998; 46: 529–537.
35.
WolkowitzOMReusVIRobertsEManfrediFChanTRaumWJ: Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry1997; 41: 311–318.
36.
FrankMGHendricksSEJohnsonDRWieselerJLBurkeWJ: Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology1999; 39: 18–24.
37.
HelgasonCMFrankJLJohnsonDRFrankMGHendricksSE: The effects of St John's Wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology2000; 46: 247–251.
